Decontamination in Healthcare Conference
Early Bird Discount Offer 30% off for a limited time only. Use Discount code EARLY30 when booking online.
“The service is under the most strain it has faced since the 1990s, suffering serious shortages of vital medical equipment such as ventilators, pumps to administer drugs, and oxygen cylinders during the ongoing winter crisis.” – NHS England
Decontamination is an important factor in preventing hospital-acquired infection in primary and secondary care settings. Failing to decontaminate equipment or the environment may not always be obvious, but it can result in cross-infection and put patients at risk. The European Centre for Disease Prevention and Control (ECDC) estimates that on any given day in a European hospital, one in eighteen patients has a healthcare-associated infection (HAI). According to a report by National Institute for Health and Care Excellence (NICE), the estimated number of patients in UK acquiring HAIs is approximately 300,000 a year, which costs the NHS approximately £1 billion a year.
In the chancellor's November budget statement, Phillip Hammond pledged £2.8bn towards improving A&E performance, reducing waiting times for patients, and treating more people this winter. The NHS should have sufficient supplies to deal with periods of increased demand however if there are shortages, are national NHS organisations ready to work with hospitals to ensure a steady supply?
Join us for the Decontamination in Healthcare Conference where leading experts from hospitals, academia, and government will discuss the innovations, challenges, and future aspects of infection control, decontamination, and sterilisation.
Please register interest below and we will keep you updated
The conference will bring together professionals from health and social care, academia, and the wider public, private and third sectors working around infection control, decontamination and sterilisation, providing a rare chance to engage with and learn from each other.
The programme has been designed to offer maximum practical value, featuring a mix of keynote speeches, service-user presentations, and case studies from those who are doing things well.
Registration and Networking
Opening Remarks from Chair
Overview of the regulations
KEYNOTE – Dr Christian Schneider, Director of National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHPR) (Invited)
Dr Christian Schneider joined the National Institute for Biological Standards and Control (NIBSC) in January 2016, taking over as Director in April 2016. NIBSC is a centre of the Medicines and Healthcare products Regulatory Agency (MHRA).
Christian is qualified in medicine and previously worked as Medical Head of Division Medicines Licensing and Availability at the Danish Medicines Agency, Head of Division EU Cooperation/Microbiology at the Paul-Ehrlich Institute in Germany, and was a postdoctoral researcher at the Max-Planck-Institute for Neurobiology (Germany).
He has a strong scientific background with an extensive publication record and a wealth of experience with a broad range of biological medicinal products.
Christian is also a former Chair of the Committee for Advanced Therapies at the European Medicines Agency (EMA), and former Chair of EMA’s Biosimilar Working Party, as well as being a former co-opted member of EMA’s Committee for Medicinal Products for Human Use (CHMP) (co-opted because of his expertise in the quality and safety of biological medicinal products).
Christian also acts as Head of Profession for scientists and engineers with in the Medicines and Healthcare products Regulatory Agency as a whole.
Research from across the globe
KEYNOTE – Professor Bill Keevil, Chair, Environmental Healthcare University of Southampton and Former Specialist Advisor to the House of Commons
Bill is Professor of Environmental Healthcare and Heads the Microbiology Group in Biological Sciences at University of Southampton, working on rapid detection of infectious agents in the natural and built environments, and developing decontamination strategies for antimicrobial resistant bacteria, biofilms, viruses and prions. He formerly worked as Head of Microbial Technology Department and Scientific Leader at CAMR, Porton Down where he developed the continuous culture biofilm fermenter, and artificial urine and saliva media for biofilm studies. He gave the first description of 3D polymicrobial biofilm structures and initiated his work on antimicrobial copper in drinking water systems. He moved to University of Southampton as Director of the Environmental Healthcare Unit in 2001 where he elucidated the mechanisms of antimicrobial copper touch surfaces and was co-inventor of the EDIC microscope for high resolution detection of bacteria, biofilms and CJD prions on complex surfaces. He is a Fellow of the American Academy of Microbiology and former Scientific Advisor to the House of Commons Science & Technology Committee.
Refreshments and Networking
Case Study to be delivered by: TBC
Education and training
Sylvia Martin, Decontamination Lead, Eastwood Park (Invited)
Sylvia Martin’s career spans 25 years, playing a central role in developing and delivering Eastwood Park’s Decontamination Lead course.
As a highly experienced Decontamination and Sterile Services Manager, Sylvia brings extensive knowledge to her training, encompassing: project management for developing business cases; the design and build of decontamination facilities; and management of full decontamination services including endoscopy and medical equipment.
Eastwood Park, Falfield, was formerly the NHS national training centre for healthcare engineering and now, as an independent company, we are the leading provider of technical healthcare engineering training in the UK.
Lunch and Networking
Challenges of Transitioning Patients from Secondary Care to Primary Care
Dr Richard Catlin Assistant Director of Infection Prevention and Control Bolton NHS Foundation Trust (Invited)
Rick Catlin, Assistant Director of Infection Prevention and Control, Bolton NHS Foundation Trust and leads the agenda for the group. Rick has a long standing interest and extensive experience in IPC as well as substantial experience of working in hospice care.
Case Study to be delivered by: TBC
Refreshments and Networking
Improving quality of care and patient journey through a patient hand hygiene QI programme.
Quality improvement methodology provides a tool for testing a change; however staff engagement is pivotal for sustained transformation in complex social behaviours and associated reduction in HCAIs.
Claire Chadwick, IPS Board Member/Deputy Treasurer and Head Nurse - Infection Prevention and Control, Pennine Acute NHS Trust: Northern Care Alliance (Invited)
Experience in leading Infection prevention and control services for 23 years within Greater Manchester and currently Head of Infection Prevention Services at Pennine Acute NHS Trust. National work has included DoH working party for HBN 00 09 Infection Control in the Built Environment and National working party for Guidelines for the Control of VRE. Currently Deputy Treasurer and member of the Board of the Infection Prevention Society.
Surgical Instruments—Back to Basics
Daniel Coole, Chair, ABHI Surgical Instrument Group (Invited)
ABHI is the UK’s lead medical technology trade association. We are a community of over 260 members, and champion the use of safe and effective medical technologies to support high quality patient outcomes and health system efficiency. Members include leading multinationals through to small and medium sized enterprises. We represent the industry to key stakeholders, such as the Government, NHS and regulators.
Closing Remarks from Chair
|Date||Venue||Price from:||Status||Spaces||Book Now||Enquire|
* Be inspired by examples of best practice from leading organisations across the health and social care sector.
* Debate ideas to improve infection control in healthcare.
* Gain new ideas, new thinking and new contacts.
* Network with a wide range of organisations all dedicated to reducing infection in a healthcare setting.
* Benefit from the opportunity to question, discuss and debate the very latest policies, projects and emerging models of care.
* Take advantage of excellent networking and knowledge-sharing opportunities.
* Share you own stories and experiences with the conference and contribute to wider thinking about dementia care and support.
* Have a full understanding of the threat that antibiotic resistance poses to the NHS and public health in the UK.
* Identify the role different areas of the NHS have to play in preventing and managing the spread of infections
* Understand how nurses, and other health care professionals working closely with patients, can take a leading role in reducing infections.
* Be fully aware of the latest innovations in technology and how they are improving outcomes in infection prevention.
* Anticipate how the move to community based care will change the approach to infection prevention and the new challenges this will present.
* Provide an understanding of decontamination practices and the development of technologies for cleaning and control of infection to a wide audience interested in public health, including healthcare specialists, scientists, students or patients.
* Discusses decontamination processes in the UK.
* Provides an in-depth understanding into decontamination in healthcare settings, specifically hospitals.
Who should attend?
Infection Control Department
Director Infection Prevention and Control
Assistant Director Infection Prevention and Control
Lead Nurse Infection Prevention and Control
Matron / Nurse
Infection Prevention and Control Nurse/Practitioner
Consultant Nurses / Specialists
Theatre Managers & Lead
Clinical Managers & Lead
Sterile Services Managers & Lead